Most Read Articles
4 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
6 days ago
Atrial fibrillation (AF) carries an excess risk of stroke recurrence independent of comorbidity with and heart failure (HF), while HF without AF also poses a significant risk of recurrence, a study has shown.
Roshini Claire Anthony, 3 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

3 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.

Evolving concepts in COPD care: NAC in focus

27 Dec 2018
Cough is a common symptom and a healthcare concern in our society today. In The Cathay Drug-sponsored Fluimucil Summit on 5 July 2018 at Makati Shangri-La Hotel in Makati City, specialists in the fields of pulmonology and research discussed the emerging updates in the management of chronic obstructive pulmonary disease (COPD) and the promising evidences on the use of N-acetylcysteine (NAC).

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Philippines digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
6 days ago
Atrial fibrillation (AF) carries an excess risk of stroke recurrence independent of comorbidity with and heart failure (HF), while HF without AF also poses a significant risk of recurrence, a study has shown.
Roshini Claire Anthony, 3 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

3 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.